Picture of Vericel logo

VCEL — Vericel News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Vericel Corp reports results for the quarter ended in March - Earnings Summary

* Vericel Corp  VCEL.OQ  reported a quarterly adjusted loss of 7
cents​​ per share for the quarter ended in March. The mean
expectation of eight analysts for the quarter was for a loss
of 4 cents per share.
* Revenue rose 26% to $33.63 million from a year ago​;  analysts
expected $32.05 million.
* Vericel Corp's reported EPS for the quarter was a loss of 7
cents​.
* The mean earnings estimate of analysts had fallen by
about 180.9% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Vericel Corp shares had risen by 6.5% this quarter and
gained 91.5% so far this year.
* The company reported a quarterly loss of $3.29 million.
* Wall Street's median 12-month price target for Vericel Corp is
$60.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 5 at 02:16 p.m. GMT. ​All
figures in US Dollars.​

Recent news on Vericel

See all news